Valuation: ViaDerma, Inc.

Market Cap 6.31M 5.54M 5.17M 4.75M 8.89M 604M 9.1M 61.33M 23.98M 299M 23.67M 23.16M 1.03B P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 6.6M 5.8M 5.42M 4.97M 9.3M 632M 9.53M 64.22M 25.11M 313M 24.79M 24.25M 1.08B EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
1 day-25.00%
1 week-25.00%
Current month-25.00%
1 month-25.00%
3 months-25.00%
6 months-25.00%
Current year+50.00%
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.01
3 years 0
Extreme 0
0.02
5 years 0
Extreme 0
0.03
10 years 0
Extreme 0
0.08
Manager TitleAgeSince
Chief Executive Officer - 31/03/2014
Director TitleAgeSince
Chairman - 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-25.00%-25.00%-50.00%-97.20% 1.23K
+0.43%+6.49%+0.56%+14.29% 48.95B
+1.90%+24.70%+27.25%+9.47% 40.75B
-1.60%-1.15%+388.84%+603.70% 38.46B
-0.98%+2.28%+7.02%+45.34% 36.38B
+1.47%+5.82%+5.76%+43.52% 28.45B
-0.94%+0.05% - - 16.62B
+2.44%+10.76%+30.59%+129.56% 16.33B
-1.14%+6.52%-3.80%-29.33% 13.65B
+0.09%+3.99%+4.06%+9.88% 13.56B
Average -2.52%+5.21%+45.59%+81.02% 25.31B
Weighted average by Cap. -0.09%+6.92%+71.94%+122.79%

Financials

2015 2016
Net sales 192K 169K 157K 144K 270K 18.37M 277K 1.87M 729K 9.09M 720K 704K 31.42M 252K 221K 207K 190K 355K 24.14M 364K 2.45M 958K 11.94M 946K 926K 41.29M
Net income 27.12K 23.83K 22.24K 20.41K 38.22K 2.6M 39.16K 264K 103K 1.29M 102K 99.62K 4.44M -122K -107K -99.91K -91.69K -172K -11.67M -176K -1.18M -463K -5.77M -457K -447K -19.96M
Net Debt 288K 253K 236K 217K 406K 27.61M 416K 2.8M 1.1M 13.66M 1.08M 1.06M 47.23M 297K 261K 243K 223K 418K 28.43M 428K 2.89M 1.13M 14.07M 1.11M 1.09M 48.63M
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
75
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. VDRM Stock